The role of phosphodiesterase 5 inhibitors in the treatment of lower urinary tract symptoms: an evidence based review. Rev Port Med Geral Fam [Internet]. 2016 Jul. 1 [cited 2026 Apr. 18];32(4):257-64. Available from: https://rpmgf.pt/ojs/index.php/rpmgf/article/view/11826